Skip to main content
NCBI home page
Microbiology and Molecular Biology Reviews : MMBR logoLink to Microbiology and Molecular Biology Reviews : MMBR
. 1997 Mar;61(1):65–89. doi: 10.1128/mmbr.61.1.65-89.1997

Potential virulence factors of Proteus bacilli.

A Rózalski 1, Z Sidorczyk 1, K Kotełko 1
PMCID: PMC232601  PMID: 9106365

Abstract

The object of this review is the genus Proteus, which contains bacteria considered now to belong to the opportunistic pathogens. Widely distributed in nature (in soil, water, and sewage), Proteus species play a significant ecological role. When present in the niches of higher macroorganisms, these species are able to evoke pathological events in different regions of the human body. The invaders (Proteus mirabilis, P. vulgaris, and P. penneri) have numerous factors including fimbriae, flagella, outer membrane proteins, lipopolysaccharide, capsule antigen, urease, immunoglobulin A proteases, hemolysins, amino acid deaminases, and, finally, the most characteristic attribute of Proteus, swarming growth, enabling them to colonize and survive in higher organisms. All these features and factors are described and commented on in detail. The questions important for future investigation of these facultatively pathogenic microorganisms are also discussed.

Full Text

The Full Text of this article is available as a PDF (379.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adegbola R. A., Old D. C., Senior B. W. The adhesins and fimbriae of Proteus mirabilis strains associated with high and low affinity for the urinary tract. J Med Microbiol. 1983 Nov;16(4):427–431. doi: 10.1099/00222615-16-4-427. [DOI] [PubMed] [Google Scholar]
  2. Alberti L., Harshey R. M. Differentiation of Serratia marcescens 274 into swimmer and swarmer cells. J Bacteriol. 1990 Aug;172(8):4322–4328. doi: 10.1128/jb.172.8.4322-4328.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Allison C., Coleman N., Jones P. L., Hughes C. Ability of Proteus mirabilis to invade human urothelial cells is coupled to motility and swarming differentiation. Infect Immun. 1992 Nov;60(11):4740–4746. doi: 10.1128/iai.60.11.4740-4746.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Allison C., Emödy L., Coleman N., Hughes C. The role of swarm cell differentiation and multicellular migration in the uropathogenicity of Proteus mirabilis. J Infect Dis. 1994 May;169(5):1155–1158. doi: 10.1093/infdis/169.5.1155. [DOI] [PubMed] [Google Scholar]
  5. Allison C., Lai H. C., Gygi D., Hughes C. Cell differentiation of Proteus mirabilis is initiated by glutamine, a specific chemoattractant for swarming cells. Mol Microbiol. 1993 Apr;8(1):53–60. doi: 10.1111/j.1365-2958.1993.tb01202.x. [DOI] [PubMed] [Google Scholar]
  6. Allison C., Lai H. C., Hughes C. Co-ordinate expression of virulence genes during swarm-cell differentiation and population migration of Proteus mirabilis. Mol Microbiol. 1992 Jun;6(12):1583–1591. doi: 10.1111/j.1365-2958.1992.tb00883.x. [DOI] [PubMed] [Google Scholar]
  7. Amano K., Fujita M., Suto T. Chemical properties of lipopolysaccharides from spotted fever group rickettsiae and their common antigenicity with lipopolysaccharides from Proteus species. Infect Immun. 1993 Oct;61(10):4350–4355. doi: 10.1128/iai.61.10.4350-4355.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Amano K., Hatakeyama H., Okuta M., Suto T., Mahara F. Serological studies of antigenic similarity between Japanese spotted fever rickettsiae and Weil-Felix test antigens. J Clin Microbiol. 1992 Sep;30(9):2441–2446. doi: 10.1128/jcm.30.9.2441-2446.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Amano K., Mizushiri S., Fujii S., Fukushi K., Suto T. Immunological characterization of lipopolysaccharides from Proteus strains used in Weil-Felix test and reactivity with patient sera of tsutsugamushi diseases. Microbiol Immunol. 1990;34(2):135–145. doi: 10.1111/j.1348-0421.1990.tb00998.x. [DOI] [PubMed] [Google Scholar]
  10. Armitage J. P., Smith D. G., Rowbury R. J. Alterations in the cell envelope composition of Proteus mirabilis during the development of swarmer cells. Biochim Biophys Acta. 1979 May 16;584(3):389–397. doi: 10.1016/0304-4165(79)90115-6. [DOI] [PubMed] [Google Scholar]
  11. Aronson M., Medalia O., Schori L., Mirelman D., Sharon N., Ofek I. Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl alpha-D-mannopyranoside. J Infect Dis. 1979 Mar;139(3):329–332. doi: 10.1093/infdis/139.3.329. [DOI] [PubMed] [Google Scholar]
  12. BRAUDE A. I., SIEMIENSKI J. Role of bacterial urease in experimental pyelonephritis. J Bacteriol. 1960 Aug;80:171–179. doi: 10.1128/jb.80.2.171-179.1960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bahrani F. K., Cook S., Hull R. A., Massad G., Mobley H. L. Proteus mirabilis fimbriae: N-terminal amino acid sequence of a major fimbrial subunit and nucleotide sequences of the genes from two strains. Infect Immun. 1993 Mar;61(3):884–891. doi: 10.1128/iai.61.3.884-891.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Bahrani F. K., Johnson D. E., Robbins D., Mobley H. L. Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection. Infect Immun. 1991 Oct;59(10):3574–3580. doi: 10.1128/iai.59.10.3574-3580.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Bahrani F. K., Massad G., Lockatell C. V., Johnson D. E., Russell R. G., Warren J. W., Mobley H. L. Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection. Infect Immun. 1994 Aug;62(8):3363–3371. doi: 10.1128/iai.62.8.3363-3371.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bahrani F. K., Mobley H. L. Proteus mirabilis MR/P fimbriae: molecular cloning, expression, and nucleotide sequence of the major fimbrial subunit gene. J Bacteriol. 1993 Jan;175(2):457–464. doi: 10.1128/jb.175.2.457-464.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Bangert R. L., Ward A. C., Stauber E. H., Cho B. R., Widders P. R. A survey of the aerobic bacteria in the feces of captive raptors. Avian Dis. 1988 Jan-Mar;32(1):53–62. [PubMed] [Google Scholar]
  18. Bartodziejska B., Radziejewska-Lebrecht J., Lipinska M., Knirel Y. A., Kononov L. O., Chernyak A. Y., Mayer H., Rozalski A. Structural and immunochemical studies on the lipopolysaccharide of the 'T-antigen'-containing mutant Proteus mirabilis R14/1959. FEMS Immunol Med Microbiol. 1996 Feb;13(2):113–121. doi: 10.1016/0928-8244(95)00092-5. [DOI] [PubMed] [Google Scholar]
  19. Bartodziejska B., Radziejewska-Lebrecht J., Lipińska M., Ziókowski A., Rózalski A. Badania swoistości epitopowej przeciwciał poliklonalnych przeciwko mutantom R Proteus mirabilis. Med Dosw Mikrobiol. 1993;45(1):99–102. [PubMed] [Google Scholar]
  20. Basu S., Radziejewska-Lebrecht J., Mayer H. Lipopolysaccharide of Providencia rettgeri. Chemical studies and taxonomical implications. Arch Microbiol. 1986 Apr;144(3):213–218. doi: 10.1007/BF00410949. [DOI] [PubMed] [Google Scholar]
  21. Belas R., Erskine D., Flaherty D. Proteus mirabilis mutants defective in swarmer cell differentiation and multicellular behavior. J Bacteriol. 1991 Oct;173(19):6279–6288. doi: 10.1128/jb.173.19.6279-6288.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Belas R., Erskine D., Flaherty D. Transposon mutagenesis in Proteus mirabilis. J Bacteriol. 1991 Oct;173(19):6289–6293. doi: 10.1128/jb.173.19.6289-6293.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Belas R. Expression of multiple flagellin-encoding genes of Proteus mirabilis. J Bacteriol. 1994 Dec;176(23):7169–7181. doi: 10.1128/jb.176.23.7169-7181.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Belas R., Flaherty D. Sequence and genetic analysis of multiple flagellin-encoding genes from Proteus mirabilis. Gene. 1994 Oct 11;148(1):33–41. doi: 10.1016/0378-1119(94)90230-5. [DOI] [PubMed] [Google Scholar]
  25. Belas R., Goldman M., Ashliman K. Genetic analysis of Proteus mirabilis mutants defective in swarmer cell elongation. J Bacteriol. 1995 Feb;177(3):823–828. doi: 10.1128/jb.177.3.823-828.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Benz R., Hardie K. R., Hughes C. Pore formation in artificial membranes by the secreted hemolysins of Proteus vulgaris and Morganella morganii. Eur J Biochem. 1994 Mar 1;220(2):339–347. doi: 10.1111/j.1432-1033.1994.tb18630.x. [DOI] [PubMed] [Google Scholar]
  27. Bergström T. Sex differences in childhood urinary tract infection. Arch Dis Child. 1972 Apr;47(252):227–232. doi: 10.1136/adc.47.252.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Berner I., Konetschny-Rapp S., Jung G., Winkelmann G. Characterization of ferrioxamine E as the principal siderophore of Erwinia herbicola (Enterobacter agglomerans). Biol Met. 1988;1(1):51–56. doi: 10.1007/BF01128017. [DOI] [PubMed] [Google Scholar]
  29. Bessler W. G., Henning U. Protein I and protein II from the outer membrane of Escherichia coli are mouse B-lymphocyte mitogens. Z Immunitatsforsch Immunobiol. 1979 Jun;155(5):387–398. [PubMed] [Google Scholar]
  30. Beynon L. M., Dumanski A. J., McLean R. J., MacLean L. L., Richards J. C., Perry M. B. Capsule structure of Proteus mirabilis (ATCC 49565). J Bacteriol. 1992 Apr;174(7):2172–2177. doi: 10.1128/jb.174.7.2172-2177.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Bijlsma I. G., van Dijk L., Kusters J. G., Gaastra W. Nucleotide sequences of two fimbrial major subunit genes, pmpA and ucaA, from canine-uropathogenic Proteus mirabilis strains. Microbiology. 1995 Jun;141(Pt 6):1349–1357. doi: 10.1099/13500872-141-6-1349. [DOI] [PubMed] [Google Scholar]
  32. Boll M., Radziejewska-Lebrecht J., Warth C., Krajewska-Pietrasik D., Mayer H. 4-Amino-4-deoxy-L-arabinose in LPS of enterobacterial R-mutants and its possible role for their polymyxin reactivity. FEMS Immunol Med Microbiol. 1994 May;8(4):329–341. doi: 10.1111/j.1574-695X.1994.tb00460.x. [DOI] [PubMed] [Google Scholar]
  33. Braun V., Focareta T. Pore-forming bacterial protein hemolysins (cytolysins). Crit Rev Microbiol. 1991;18(2):115–158. doi: 10.3109/10408419109113511. [DOI] [PubMed] [Google Scholar]
  34. Breitenbach J. M., Hausinger R. P. Proteus mirabilis urease. Partial purification and inhibition by boric acid and boronic acids. Biochem J. 1988 Mar 15;250(3):917–920. doi: 10.1042/bj2500917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Brinton C. C., Jr The structure, function, synthesis and genetic control of bacterial pili and a molecular model for DNA and RNA transport in gram negative bacteria. Trans N Y Acad Sci. 1965 Jun;27(8):1003–1054. doi: 10.1111/j.2164-0947.1965.tb02342.x. [DOI] [PubMed] [Google Scholar]
  36. Brubaker R. R. Mechanisms of bacterial virulence. Annu Rev Microbiol. 1985;39:21–50. doi: 10.1146/annurev.mi.39.100185.000321. [DOI] [PubMed] [Google Scholar]
  37. Bub F., Bieker P., Martin H. H., Nixdorff K. Immunological characterization of two major proteins isolated from the outer membrane of Proteus mirabilis. Infect Immun. 1980 Feb;27(2):315–321. doi: 10.1128/iai.27.2.315-321.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Capodici C., Chen S., Sidorczyk Z., Elsbach P., Weiss J. Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli. Infect Immun. 1994 Jan;62(1):259–265. doi: 10.1128/iai.62.1.259-265.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Cavaillon J. M., Haeffner-Cavaillon N. Polymyxin-B inhibition of LPS-induced interleukin-1 secretion by human monocytes is dependent upon the LPS origin. Mol Immunol. 1986 Sep;23(9):965–969. doi: 10.1016/0161-5890(86)90127-6. [DOI] [PubMed] [Google Scholar]
  40. Cedzyński M., Knirel Y. A., Rózalski A., Shashkov A. S., Vinogradov E. V., Kaca W. The structure and serological specificity of Proteus mirabilis O43 O antigen. Eur J Biochem. 1995 Sep 1;232(2):558–562. doi: 10.1111/j.1432-1033.1995.tb20844.x. [DOI] [PubMed] [Google Scholar]
  41. Cedzyński M., Rózalski A., Kotełko K., Kaca W., Vinogradov E. V., Knirel Y. A., Kochetkov N. K. Badania strukturalne i immunologiczne polisacharydu O-swoistego Proteus mirabilis 033. Med Dosw Mikrobiol. 1993;45(1):93–97. [PubMed] [Google Scholar]
  42. Cellini L., Piccolomini R., Allocati N., Ravagnan G. Adhesive properties of Proteus genus related to antimicrobial agents resistance. Microbiologica. 1987 Jul;10(3):291–299. [PubMed] [Google Scholar]
  43. Chang C. C., Merritt K. Effect of Staphylococcus epidermidis on adherence of Pseudomonas aeruginosa and Proteus mirabilis to polymethyl methacrylate (PMMA) and gentamicin-containing PMMA. J Orthop Res. 1991 Mar;9(2):284–288. doi: 10.1002/jor.1100090217. [DOI] [PubMed] [Google Scholar]
  44. Chen Y. H., Hancock R. E., Mishell R. I. Mitogenic effects of purified outer membrane proteins from Pseudomonas aeruginosa. Infect Immun. 1980 Apr;28(1):178–184. doi: 10.1128/iai.28.1.178-184.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Cheng K. J., Irvin R. T., Costerton J. W. Autochthonous and pathogenic colonization of animal tissues by bacteria. Can J Microbiol. 1981 May;27(5):461–490. doi: 10.1139/m81-071. [DOI] [PubMed] [Google Scholar]
  46. Chernyak AYa, Kononov L. O., Krishna P. R., Kochetkov N. K., Rao A. V. Synthesis of lysine-containing fragments of the Proteus mirabilis O27 O-specific polysaccharide and neoglycoconjugates therefrom. Carbohydr Res. 1992 Mar 2;225(2):279–289. doi: 10.1016/s0008-6215(00)90501-9. [DOI] [PubMed] [Google Scholar]
  47. Cherry W. B., Lentz P. L., Barnes L. A. Implication of Proteus mirabilis in an Outbreak of Gastroenteritis. Am J Public Health Nations Health. 1946 May;36(5):484–488. [PMC free article] [PubMed] [Google Scholar]
  48. Chippendale G. R., Warren J. W., Trifillis A. L., Mobley H. L. Internalization of Proteus mirabilis by human renal epithelial cells. Infect Immun. 1994 Aug;62(8):3115–3121. doi: 10.1128/iai.62.8.3115-3121.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Chow A. W., Taylor P. R., Yoshikawa T. T., Guze L. B. A nosocomial outbreak of infections due to multiply resistant Proteus mirabilis: role of intestinal colonization as a major reservoir. J Infect Dis. 1979 Jun;139(6):621–627. doi: 10.1093/infdis/139.6.621. [DOI] [PubMed] [Google Scholar]
  50. Clegg S., Gerlach G. F. Enterobacterial fimbriae. J Bacteriol. 1987 Mar;169(3):934–938. doi: 10.1128/jb.169.3.934-938.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Cook S. W., Mody N., Valle J., Hull R. Molecular cloning of Proteus mirabilis uroepithelial cell adherence (uca) genes. Infect Immun. 1995 May;63(5):2082–2086. doi: 10.1128/iai.63.5.2082-2086.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Cosenza B. J., Podgwaite J. D. A new species of Proteus isolated from larvae of the gypsy moth Porthetria dispar (L.). Antonie Van Leeuwenhoek. 1966;32(2):187–191. doi: 10.1007/BF02097459. [DOI] [PubMed] [Google Scholar]
  53. Costas M., Holmes B., Frith K. A., Riddle C., Hawkey P. M. Identification and typing of Proteus penneri and Proteus vulgaris biogroups 2 and 3, from clinical sources, by computerized analysis of electrophoretic protein patterns. J Appl Bacteriol. 1993 Nov;75(5):489–498. doi: 10.1111/j.1365-2672.1993.tb02806.x. [DOI] [PubMed] [Google Scholar]
  54. Coyne C. P., Fenwick B. W. Inhibition of lipopolysaccharide-induced macrophage tumor necrosis factor-alpha synthesis by polymyxin B sulfate. Am J Vet Res. 1993 Feb;54(2):305–314. [PubMed] [Google Scholar]
  55. DUTTON A. A., RALSTON M. Urinary tract infection in a male urological ward; with special reference to the mode of infection. Lancet. 1957 Jan 19;272(6960):115–119. [PubMed] [Google Scholar]
  56. Datta D. B., Krämer C., Henning U. Diploidy for a structural gene specifying a major protein of the outer cell envelope membrane from Escherichia coli K-12. J Bacteriol. 1976 Dec;128(3):834–841. doi: 10.1128/jb.128.3.834-841.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Deighton C. M., Gray J. W., Bint A. J., Walker D. J. Anti-Proteus antibodies in rheumatoid arthritis same-sexed sibships. Br J Rheumatol. 1992 Apr;31(4):241–245. doi: 10.1093/rheumatology/31.4.241. [DOI] [PubMed] [Google Scholar]
  58. Drechsel H., Thieken A., Reissbrodt R., Jung G., Winkelmann G. Alpha-keto acids are novel siderophores in the genera Proteus, Providencia, and Morganella and are produced by amino acid deaminases. J Bacteriol. 1993 May;175(9):2727–2733. doi: 10.1128/jb.175.9.2727-2733.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Dumanski A. J., Hedelin H., Edin-Liljegren A., Beauchemin D., McLean R. J. Unique ability of the Proteus mirabilis capsule to enhance mineral growth in infectious urinary calculi. Infect Immun. 1994 Jul;62(7):2998–3003. doi: 10.1128/iai.62.7.2998-3003.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Ebringer A., Khalafpour S., Wilson C. Rheumatoid arthritis and Proteus: a possible aetiological association. Rheumatol Int. 1989;9(3-5):223–228. doi: 10.1007/BF00271885. [DOI] [PubMed] [Google Scholar]
  61. Edén C. S., Hagberg L., Hanson L. A., Korhonen T., Leffler H., Olling S. Adhesion of Escherichia coli in urinary tract infection. Ciba Found Symp. 1981;80:161–187. doi: 10.1002/9780470720639.ch11. [DOI] [PubMed] [Google Scholar]
  62. Edén C. S., Larsson P., Lomberg H. Attachment of Proteus mirabilis to human urinary sediment epithelial cells in vitro is different from that of Escherichia coli. Infect Immun. 1980 Mar;27(3):804–807. doi: 10.1128/iai.27.3.804-807.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Engler H. D., Troy K., Bottone E. J. Bacteremia and subcutaneous abscess caused by Proteus penneri in a neutropenic host. J Clin Microbiol. 1990 Jul;28(7):1645–1646. doi: 10.1128/jcm.28.7.1645-1646.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Evanylo L. P., Kadis S., Maudsley J. R. Siderophore production by Proteus mirabilis. Can J Microbiol. 1984 Aug;30(8):1046–1051. doi: 10.1139/m84-163. [DOI] [PubMed] [Google Scholar]
  65. Farmer J. J., 3rd, Davis B. R., Hickman-Brenner F. W., McWhorter A., Huntley-Carter G. P., Asbury M. A., Riddle C., Wathen-Grady H. G., Elias C., Fanning G. R. Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens. J Clin Microbiol. 1985 Jan;21(1):46–76. doi: 10.1128/jcm.21.1.46-76.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Finlay B. B. Cell adhesion and invasion mechanisms in microbial pathogenesis. Curr Opin Cell Biol. 1990 Oct;2(5):815–820. doi: 10.1016/0955-0674(90)90078-s. [DOI] [PubMed] [Google Scholar]
  67. Finlay B. B., Falkow S. Common themes in microbial pathogenicity. Microbiol Rev. 1989 Jun;53(2):210–230. doi: 10.1128/mr.53.2.210-230.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Fuksa M., Krajden S., Lee A. Susceptibilities of 45 clinical isolates of Proteus penneri. Antimicrob Agents Chemother. 1984 Sep;26(3):419–420. doi: 10.1128/aac.26.3.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. GORRILL R. H. THE FATE OF PSEUDOMONAS AERUGINOSA, PROTEUS MIRABILIS AND ESCHERICHIA COLI IN THE MOUSE KIDNEY. J Pathol Bacteriol. 1965 Jan;89:81–88. doi: 10.1002/path.1700890110. [DOI] [PubMed] [Google Scholar]
  70. GRABER C. D., LINCOLN A. F. Infantile diarrhea in the Denver area: significance of Proteus-Providencia organisms. Pediatrics. 1955 Nov;16(5):585–589. [PubMed] [Google Scholar]
  71. GUO M. M., LIU P. V. SEROLOGICAL SPECIFICITIES OF UREASES OF PROTEUS SPECIES. J Gen Microbiol. 1965 Mar;38:417–422. doi: 10.1099/00221287-38-3-417. [DOI] [PubMed] [Google Scholar]
  72. Gabidullin Z. G., Ishkil'din I. B. Morfologicheskie svoistva i adgezivnost' bakterii roda Proteus. Zh Mikrobiol Epidemiol Immunobiol. 1989 Jun;(6):83–86. [PubMed] [Google Scholar]
  73. Gaillard J. L., Berche P., Frehel C., Gouin E., Cossart P. Entry of L. monocytogenes into cells is mediated by internalin, a repeat protein reminiscent of surface antigens from gram-positive cocci. Cell. 1991 Jun 28;65(7):1127–1141. doi: 10.1016/0092-8674(91)90009-n. [DOI] [PubMed] [Google Scholar]
  74. Gibson F., Magrath D. I. The isolation and characterization of a hydroxamic acid (aerobactin) formed by Aerobacter aerogenes 62-I. Biochim Biophys Acta. 1969 Nov 18;192(2):175–184. doi: 10.1016/0304-4165(69)90353-5. [DOI] [PubMed] [Google Scholar]
  75. Grace M. E., Gregory F. J., Hung P. P., Fu K. P. Purification and properties of a beta-lactamase from Proteus penneri. J Antibiot (Tokyo) 1986 Jul;39(7):938–942. doi: 10.7164/antibiotics.39.938. [DOI] [PubMed] [Google Scholar]
  76. Griffith D. P., Musher D. M., Itin C. Urease. The primary cause of infection-induced urinary stones. Invest Urol. 1976 Mar;13(5):346–350. [PubMed] [Google Scholar]
  77. Gromska W., Kaca W., Kotełko K. The role of lysine in the serological specificity of some proteus mirabilis lipopolysaccharides. Bull Acad Pol Sci Biol. 1978;26(1):7–13. [PubMed] [Google Scholar]
  78. Gromska W., Mayer H. The linkage of lysine in the O-specific chains of Proteus mirabilis 1959. Eur J Biochem. 1976 Feb 16;62(2):391–399. doi: 10.1111/j.1432-1033.1976.tb10171.x. [DOI] [PubMed] [Google Scholar]
  79. Guentzel M. N., Berry L. J. Motility as a virulence factor for Vibrio cholerae. Infect Immun. 1975 May;11(5):890–897. doi: 10.1128/iai.11.5.890-897.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Gygi D., Bailey M. J., Allison C., Hughes C. Requirement for FlhA in flagella assembly and swarm-cell differentiation by Proteus mirabilis. Mol Microbiol. 1995 Feb;15(4):761–769. doi: 10.1111/j.1365-2958.1995.tb02383.x. [DOI] [PubMed] [Google Scholar]
  81. Gygi D., Rahman M. M., Lai H. C., Carlson R., Guard-Petter J., Hughes C. A cell-surface polysaccharide that facilitates rapid population migration by differentiated swarm cells of Proteus mirabilis. Mol Microbiol. 1995 Sep;17(6):1167–1175. doi: 10.1111/j.1365-2958.1995.mmi_17061167.x. [DOI] [PubMed] [Google Scholar]
  82. Hasin M., Rottem S., Razin S. The outer membrane of Proteus mirabilis. I. Isolation and characterization of the outer and cytoplasmic membrane fractions. Biochim Biophys Acta. 1975 Feb 14;375(3):381–394. doi: 10.1016/0005-2736(75)90354-5. [DOI] [PubMed] [Google Scholar]
  83. Hausinger R. P. Nickel utilization by microorganisms. Microbiol Rev. 1987 Mar;51(1):22–42. doi: 10.1128/mr.51.1.22-42.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Hawkey P. M., Hawkey C. A. Comparative in-vitro activity of quinolone carboxylic acids against Proteeae. J Antimicrob Chemother. 1984 Nov;14(5):485–489. doi: 10.1093/jac/14.5.485. [DOI] [PubMed] [Google Scholar]
  85. Hawkey P. M., Pedler S. J., Turner A. Comparative in vitro activity of semisynthetic penicillins against Proteeae. Antimicrob Agents Chemother. 1983 Apr;23(4):619–621. doi: 10.1128/aac.23.4.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Hawthorn L., Reid G. The effect of protein and urine on uropathogen adhesion to polymer substrata. J Biomed Mater Res. 1990 Oct;24(10):1325–1332. doi: 10.1002/jbm.820241005. [DOI] [PubMed] [Google Scholar]
  87. Henrichsen J. Bacterial surface translocation: a survey and a classification. Bacteriol Rev. 1972 Dec;36(4):478–503. doi: 10.1128/br.36.4.478-503.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Hickman F. W., Steigerwalt A. G., Farmer J. J., 3rd, Brenner D. J. Identification of Proteus penneri sp. nov., formerly known as Proteus vulgaris indole negative or as Proteus vulgaris biogroup 1. J Clin Microbiol. 1982 Jun;15(6):1097–1102. doi: 10.1128/jcm.15.6.1097-1102.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Hofstra H., Dankert J. Antigenic cross-reactivity of major outer membrane proteins in enterobacteriaceae species. J Gen Microbiol. 1979 Apr;111(2):293–302. doi: 10.1099/00221287-111-2-293. [DOI] [PubMed] [Google Scholar]
  90. Hofstra H., Van Tol J. D., Dankert J. Cross-reactivity of major outer membrane proteins of Enterobacteriaceae, studied by crossed immunoelectrophoresis. J Bacteriol. 1980 Jul;143(1):328–337. doi: 10.1128/jb.143.1.328-337.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Holmes B., Costas M., Wood A. C. Typing of Proteus mirabilis from clinical sources by computerized analysis of electrophoretic protein patterns. J Appl Bacteriol. 1991 Nov;71(5):467–476. doi: 10.1111/j.1365-2672.1991.tb03818.x. [DOI] [PubMed] [Google Scholar]
  92. Hornick D. B., Allen B. L., Horn M. A., Clegg S. Fimbrial types among respiratory isolates belonging to the family Enterobacteriaceae. J Clin Microbiol. 1991 Sep;29(9):1795–1800. doi: 10.1128/jcm.29.9.1795-1800.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Isberg R. R., Voorhis D. L., Falkow S. Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells. Cell. 1987 Aug 28;50(5):769–778. doi: 10.1016/0092-8674(87)90335-7. [DOI] [PubMed] [Google Scholar]
  94. Island M. D., Mobley H. L. Proteus mirabilis urease: operon fusion and linker insertion analysis of ure gene organization, regulation, and function. J Bacteriol. 1995 Oct;177(19):5653–5660. doi: 10.1128/jb.177.19.5653-5660.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Johnson D. E., Russell R. G., Lockatell C. V., Zulty J. C., Warren J. W., Mobley H. L. Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection. Infect Immun. 1993 Jul;61(7):2748–2754. doi: 10.1128/iai.61.7.2748-2754.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Johnson J. R. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev. 1991 Jan;4(1):80–128. doi: 10.1128/cmr.4.1.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Jones B. D., Lockatell C. V., Johnson D. E., Warren J. W., Mobley H. L. Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection. Infect Immun. 1990 Apr;58(4):1120–1123. doi: 10.1128/iai.58.4.1120-1123.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Jones B. D., Mobley H. L. Genetic and biochemical diversity of ureases of Proteus, Providencia, and Morganella species isolated from urinary tract infection. Infect Immun. 1987 Sep;55(9):2198–2203. doi: 10.1128/iai.55.9.2198-2203.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Jones B. D., Mobley H. L. Proteus mirabilis urease: genetic organization, regulation, and expression of structural genes. J Bacteriol. 1988 Aug;170(8):3342–3349. doi: 10.1128/jb.170.8.3342-3349.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Jones B. D., Mobley H. L. Proteus mirabilis urease: nucleotide sequence determination and comparison with jack bean urease. J Bacteriol. 1989 Dec;171(12):6414–6422. doi: 10.1128/jb.171.12.6414-6422.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. KIPPAZ P. W. A study of Proteus infections in a male urological ward. J Clin Pathol. 1957 Aug;10(3):211–214. doi: 10.1136/jcp.10.3.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Kaca W., Knirel Y. A., Vinogradov E. V., Kotełko K. Structure of the 0-specific polysaccharide of Proteus mirabilis S 1959. Arch Immunol Ther Exp (Warsz) 1987;35(4):431–437. [PubMed] [Google Scholar]
  103. Kaca W., Mara M., Ocenaskova J. Inhibition of mouse liver cytochrome P-450 by gram-negative bacteria lipopolysaccharides. Arch Immunol Ther Exp (Warsz) 1996;44(1):39–44. [PubMed] [Google Scholar]
  104. Kaca W., Radziejewska-Lebrecht J., Bhat U. R. Effect of polymyxins on the lipopolysaccharide-defective mutants of Proteus mirabilis. Microbios. 1990;61(246):23–32. [PubMed] [Google Scholar]
  105. Kaca W., Roth R. I., Levin J. Hemoglobin, a newly recognized lipopolysaccharide (LPS)-binding protein that enhances LPS biological activity. J Biol Chem. 1994 Oct 7;269(40):25078–25084. [PubMed] [Google Scholar]
  106. Kaca W., Roth R. Activation of complement by human hemoglobin and by mixtures of hemoglobin and bacterial endotoxin. Biochim Biophys Acta. 1995 Aug 17;1245(1):49–56. doi: 10.1016/0304-4165(95)00077-o. [DOI] [PubMed] [Google Scholar]
  107. Kaca W., Rózalski A. Characterization of cell-bound and cell-free hemolytic activity of Proteus strains. Eur J Epidemiol. 1991 Mar;7(2):159–165. doi: 10.1007/BF00237360. [DOI] [PubMed] [Google Scholar]
  108. Kappos T., John M. A., Hussain Z., Valvano M. A. Outer membrane protein profiles and multilocus enzyme electrophoresis analysis for differentiation of clinical isolates of Proteus mirabilis and Proteus vulgaris. J Clin Microbiol. 1992 Oct;30(10):2632–2637. doi: 10.1128/jcm.30.10.2632-2637.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Karch H., Gmeiner J., Nixdorff K. Alteration of the immunoglobulin G subclass responses in mice to lipopolysaccharide: effects of nonbacterial proteins and bacterial membrane phospholipids or outer membrane proteins of Proteus mirabilis. Infect Immun. 1983 Apr;40(1):157–165. doi: 10.1128/iai.40.1.157-165.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Karch H., Nixdorff K. Antibody-producing cell responses to an isolated outer membrane protein and to complexes of this antigen with lipopolysaccharide or with vesicles of phospholipids from Proteus mirabilis. Infect Immun. 1981 Mar;31(3):862–867. doi: 10.1128/iai.31.3.862-867.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Karch H., Nixdorff K. Modulation of the IgG subclass responses to lipopolysaccharide by bacterial membrane components: differential adjuvant effects produced by primary and secondary stimulation. J Immunol. 1983 Jul;131(1):6–8. [PubMed] [Google Scholar]
  112. Knirel Y. A., Paramonov N. A., Vinogradov E. V., Kochetkov N. K., Sidorczyk Z., Zych K. 2-Acetamido-4-O-[(S)-1-carboxyethyl]-2-deoxy-D-glucose: a new natural isomer of N-acetylmuramic acid from the O-specific polysaccharide of Proteus penneri 35. Carbohydr Res. 1994 Jun 2;259(1):C1–C3. doi: 10.1016/0008-6215(94)84208-6. [DOI] [PubMed] [Google Scholar]
  113. Knirel Y. A., Paramonov N. A., Vinogradov E. V., Shashkov A. S., Kochetkov N. K., Sidorczyk Z., Swierzko A. Structure of the O-specific polysaccharide of Proteus penneri 62 containing 2-acetamido-3-O-[(S)-1-carboxyethyl]-2-deoxy-D-glucose (N-acetylisomuramic acid). Carbohydr Res. 1992 Nov 4;235:C19–C23. doi: 10.1016/0008-6215(92)80105-a. [DOI] [PubMed] [Google Scholar]
  114. Kornfeld S. J., Plaut A. G. Secretory immunity and the bacterial IgA proteases. Rev Infect Dis. 1981 May-Jun;3(3):521–534. doi: 10.1093/clinids/3.3.521. [DOI] [PubMed] [Google Scholar]
  115. Koronakis V., Cross M., Senior B., Koronakis E., Hughes C. The secreted hemolysins of Proteus mirabilis, Proteus vulgaris, and Morganella morganii are genetically related to each other and to the alpha-hemolysin of Escherichia coli. J Bacteriol. 1987 Apr;169(4):1509–1515. doi: 10.1128/jb.169.4.1509-1515.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Koronakis V., Hughes C. Identification of the promoters directing in vivo expression of hemolysin genes in Proteus vulgaris and Escherichia coli. Mol Gen Genet. 1988 Jul;213(1):99–104. doi: 10.1007/BF00333404. [DOI] [PubMed] [Google Scholar]
  117. Koronakis V., Koronakis E., Hughes C. Comparison of the haemolysin secretion protein HlyB from Proteus vulgaris and Escherichia coli; site-directed mutagenesis causing impairment of export function. Mol Gen Genet. 1988 Aug;213(2-3):551–555. doi: 10.1007/BF00339631. [DOI] [PubMed] [Google Scholar]
  118. Kotelko K., Kaca W., Rózalski A., Deka M. Some biological features of Proteus bacilli. 2. Haemolytic activities of Proteus mirabilis and Proteus vulgaris strains. Acta Microbiol Pol. 1983;32(4):345–351. [PubMed] [Google Scholar]
  119. Kotelko K. Proteus mirabilis: taxonomic position, peculiarities of growth, components of the cell envelope. Curr Top Microbiol Immunol. 1986;129:181–215. doi: 10.1007/978-3-642-71399-6_3. [DOI] [PubMed] [Google Scholar]
  120. Kotelko K., Rozalski A., Deka M., Kaca W., Sidorczyk Z., Gromska W., Zych K. Some biological features of Proteus bacilli. 1. Comparison of Proteus mirabilis strains provided from various sources. Acta Microbiol Pol. 1983;32(4):339–344. [PubMed] [Google Scholar]
  121. Kotełko K., Gromska W., Papierz M., Sidorczyk Z., Krajewska D., Szer K. Core region in Proteus mirabilis lipopolysaccharide. J Hyg Epidemiol Microbiol Immunol. 1977;21(3):271–284. [PubMed] [Google Scholar]
  122. Krajden S., Fuksa M., Lizewski W., Barton L., Lee A. Proteus penneri and urinary calculi formation. J Clin Microbiol. 1984 Apr;19(4):541–542. doi: 10.1128/jcm.19.4.541-542.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Krajden S., Fuksa M., Petrea C., Crisp L. J., Penner J. L. Expanded clinical spectrum of infections caused by Proteus penneri. J Clin Microbiol. 1987 Mar;25(3):578–579. doi: 10.1128/jcm.25.3.578-579.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Krajewska-Pietrasik D., Cherniak A. Y., Rózalski A. Próba wykorzystania antygenów syntetycznych w badaniu antygenowej swoistości lipopolisacharydu Proteus mirabilis 027. Med Dosw Mikrobiol. 1995;47(3-4):169–176. [PubMed] [Google Scholar]
  125. Krajewska-Pietrasik D., Larsson P., Zych K., Wlodarczyk J., Gromska W. Characteristics of spontaneously agglutinating Proteus mirabilis strains from bacteriuric patients. APMIS. 1991 Oct;99(10):956–960. [PubMed] [Google Scholar]
  126. Krajewska-Pietrasik D., Rózalski A., Bartodziejska B., Radziejewska-Lebrecht J., Mayer H., Kotełko K. Properties of a deep Proteus R mutant isolated from clinical material. APMIS. 1991 Jun;99(6):499–506. [PubMed] [Google Scholar]
  127. LANYI B. Serological typing of Proteus strains from infantile enteritis and other sources. Acta Microbiol Acad Sci Hung. 1956;3(4):417–428. [PubMed] [Google Scholar]
  128. Larsson P., Fasth A., Jodal U., Akerlund A. S., Edén C. S. Urinary tract infections caused by Proteus mirabilis in children. The antibody response to O and H antigens and Tamm-Horsfall protein and bacterial adherence to uro-epithelium. Acta Paediatr Scand. 1978 Sep;67(5):591–596. doi: 10.1111/j.1651-2227.1978.tb17807.x. [DOI] [PubMed] [Google Scholar]
  129. Larsson P., Olling S. 0 antigen distribution and sensitivity to the bactericidal effect of normal human serum of Proteus strains from clinical specimens. Med Microbiol Immunol. 1977 Jul 18;163(2):77–82. doi: 10.1007/BF02121822. [DOI] [PubMed] [Google Scholar]
  130. Legnani-Fajardo C., Zunino P., Algorta G., Laborde H. F. Antigenic and immunogenic activity of flagella and fimbriae preparations from uropathogenic Proteus mirabilis. Can J Microbiol. 1991 Apr;37(4):325–328. doi: 10.1139/m91-052. [DOI] [PubMed] [Google Scholar]
  131. Loomes L. M., Senior B. W., Kerr M. A. A proteolytic enzyme secreted by Proteus mirabilis degrades immunoglobulins of the immunoglobulin A1 (IgA1), IgA2, and IgG isotypes. Infect Immun. 1990 Jun;58(6):1979–1985. doi: 10.1128/iai.58.6.1979-1985.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Loomes L. M., Senior B. W., Kerr M. A. Proteinases of Proteus spp.: purification, properties, and detection in urine of infected patients. Infect Immun. 1992 Jun;60(6):2267–2273. doi: 10.1128/iai.60.6.2267-2273.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Lugtenberg B., Bronstein H., van Selm N., Peters R. Peptidoglycan-associated outer membrane proteins in gammegatine bacteria. Biochim Biophys Acta. 1977 Mar 17;465(3):571–578. doi: 10.1016/0005-2736(77)90274-7. [DOI] [PubMed] [Google Scholar]
  134. Lukomski S., Müller B., Schmidt G. Extracellular haemolysin of Proteus penneri coded by chromosomal hly genes is similar to the alpha-haemolysin of Escherichia coli. Zentralbl Bakteriol. 1990 Jun;273(2):150–155. doi: 10.1016/s0934-8840(11)80242-2. [DOI] [PubMed] [Google Scholar]
  135. Lukomski S., Pytlos M., Serwecinska L., Sidorczyk Z., Jaworski A. Analysis of antibiotic resistance determinants in Proteus penneri. Eur J Clin Microbiol Infect Dis. 1993 Jun;12(6):467–469. doi: 10.1007/BF01967445. [DOI] [PubMed] [Google Scholar]
  136. Lukomski S., Serwecińska L., Rózalski A., Dziadek J., Staczek P., Jaworski A. Cell-free and cell-bound hemolytic activities of Proteus penneri determined by different Hly determinants. Can J Microbiol. 1991 Jun;37(6):419–424. doi: 10.1139/m91-068. [DOI] [PubMed] [Google Scholar]
  137. MacLaren D. M. The significance of urease in proteus pyelonephritis: a bacteriological study. J Pathol Bacteriol. 1968 Jul;96(1):45–56. doi: 10.1002/path.1700960106. [DOI] [PubMed] [Google Scholar]
  138. MacLaren D. M. The significance of urease in proteus pyelonephritis: a histological and biochemical study. J Pathol. 1969 Jan;97(1):43–49. doi: 10.1002/path.1710970107. [DOI] [PubMed] [Google Scholar]
  139. Magaña-Plaza I., Montes C., Ruiz-Herrera J. Purification and biochemical characteristics of urease from Proteus rettgeri. Biochim Biophys Acta. 1971 Jul 21;242(1):230–237. doi: 10.1016/0005-2744(71)90103-3. [DOI] [PubMed] [Google Scholar]
  140. Magaña-Plaza I., Ruiz-Herrera J. Mechanisms of regulation of urease biosynthesis in Proteus rettgeri. J Bacteriol. 1967 Apr;93(4):1294–1301. doi: 10.1128/jb.93.4.1294-1301.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Martin M. A. Epidemiology and clinical impact of gram-negative sepsis. Infect Dis Clin North Am. 1991 Dec;5(4):739–752. [PubMed] [Google Scholar]
  142. Massad G., Bahrani F. K., Mobley H. L. Proteus mirabilis fimbriae: identification, isolation, and characterization of a new ambient-temperature fimbria. Infect Immun. 1994 May;62(5):1989–1994. doi: 10.1128/iai.62.5.1989-1994.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Massad G., Lockatell C. V., Johnson D. E., Mobley H. L. Proteus mirabilis fimbriae: construction of an isogenic pmfA mutant and analysis of virulence in a CBA mouse model of ascending urinary tract infection. Infect Immun. 1994 Feb;62(2):536–542. doi: 10.1128/iai.62.2.536-542.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Massad G., Zhao H., Mobley H. L. Proteus mirabilis amino acid deaminase: cloning, nucleotide sequence, and characterization of aad. J Bacteriol. 1995 Oct;177(20):5878–5883. doi: 10.1128/jb.177.20.5878-5883.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. McCarter L., Silverman M. Iron regulation of swarmer cell differentiation of Vibrio parahaemolyticus. J Bacteriol. 1989 Feb;171(2):731–736. doi: 10.1128/jb.171.2.731-736.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. McLean R. J., Cheng K. J., Gould W. D., Nickel J. C., Costerton J. W. Histochemical and biochemical urease localization in the periplasm and outer membrane of two Proteus mirabilis strains. Can J Microbiol. 1986 Oct;32(10):772–778. doi: 10.1139/m86-142. [DOI] [PubMed] [Google Scholar]
  147. McLean R. J., Nickel J. C., Cheng K. J., Costerton J. W. The ecology and pathogenicity of urease-producing bacteria in the urinary tract. Crit Rev Microbiol. 1988;16(1):37–79. doi: 10.3109/10408418809104467. [DOI] [PubMed] [Google Scholar]
  148. McLean R. J., Nickel J. C., Noakes V. C., Costerton J. W. An in vitro ultrastructural study of infectious kidney stone genesis. Infect Immun. 1985 Sep;49(3):805–811. doi: 10.1128/iai.49.3.805-811.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Melchers F., Braun V., Galanos C. The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen. J Exp Med. 1975 Aug 1;142(2):473–482. doi: 10.1084/jem.142.2.473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. Milazzo F. H., Delisle G. J. Immunoglobulin A proteases in gram-negative bacteria isolated from human urinary tract infections. Infect Immun. 1984 Jan;43(1):11–13. doi: 10.1128/iai.43.1.11-13.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Mizushiri S., Amano K., Fuji S., Fukushi K., Watanabe M. Chemical characterization of lipopolysaccharides from Proteus strains used in Weil-Felix test. Microbiol Immunol. 1990;34(2):121–133. doi: 10.1111/j.1348-0421.1990.tb00997.x. [DOI] [PubMed] [Google Scholar]
  152. Moayeri N., Collins C. M., O'Hanley P. Efficacy of a Proteus mirabilis outer membrane protein vaccine in preventing experimental Proteus pyelonephritis in a BALB/c mouse model. Infect Immun. 1991 Oct;59(10):3778–3786. doi: 10.1128/iai.59.10.3778-3786.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Mobley H. L., Belas R. Swarming and pathogenicity of Proteus mirabilis in the urinary tract. Trends Microbiol. 1995 Jul;3(7):280–284. doi: 10.1016/s0966-842x(00)88945-3. [DOI] [PubMed] [Google Scholar]
  154. Mobley H. L., Chippendale G. R. Hemagglutinin, urease, and hemolysin production by Proteus mirabilis from clinical sources. J Infect Dis. 1990 Mar;161(3):525–530. doi: 10.1093/infdis/161.3.525. [DOI] [PubMed] [Google Scholar]
  155. Mobley H. L., Chippendale G. R., Swihart K. G., Welch R. A. Cytotoxicity of the HpmA hemolysin and urease of Proteus mirabilis and Proteus vulgaris against cultured human renal proximal tubular epithelial cells. Infect Immun. 1991 Jun;59(6):2036–2042. doi: 10.1128/iai.59.6.2036-2042.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  156. Mobley H. L., Chippendale G. R., Tenney J. H., Mayrer A. R., Crisp L. J., Penner J. L., Warren J. W. MR/K hemagglutination of Providencia stuartii correlates with adherence to catheters and with persistence in catheter-associated bacteriuria. J Infect Dis. 1988 Feb;157(2):264–271. doi: 10.1093/infdis/157.2.264. [DOI] [PubMed] [Google Scholar]
  157. Mobley H. L., Hausinger R. P. Microbial ureases: significance, regulation, and molecular characterization. Microbiol Rev. 1989 Mar;53(1):85–108. doi: 10.1128/mr.53.1.85-108.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Mobley H. L., Island M. D., Hausinger R. P. Molecular biology of microbial ureases. Microbiol Rev. 1995 Sep;59(3):451–480. doi: 10.1128/mr.59.3.451-480.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Mobley H. L., Jones B. D., Jerse A. E. Cloning of urease gene sequences from Providencia stuartii. Infect Immun. 1986 Oct;54(1):161–169. doi: 10.1128/iai.54.1.161-169.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Mobley H. L., Jones B. D., Penner J. L. Urease activity of Proteus penneri. J Clin Microbiol. 1987 Dec;25(12):2302–2305. doi: 10.1128/jcm.25.12.2302-2305.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  161. Mobley H. L., Warren J. W. Urease-positive bacteriuria and obstruction of long-term urinary catheters. J Clin Microbiol. 1987 Nov;25(11):2216–2217. doi: 10.1128/jcm.25.11.2216-2217.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Montie T. C., Doyle-Huntzinger D., Craven R. C., Holder I. A. Loss of virulence associated with absence of flagellum in an isogenic mutant of Pseudomonas aeruginosa in the burned-mouse model. Infect Immun. 1982 Dec;38(3):1296–1298. doi: 10.1128/iai.38.3.1296-1298.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Morrison D. C., Jacobs D. M. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry. 1976 Oct;13(10):813–818. doi: 10.1016/0019-2791(76)90181-6. [DOI] [PubMed] [Google Scholar]
  164. Musher D. M., Griffith D. P., Yawn D., Rossen R. D. Role of urease in pyelonephritis resulting from urinary tract infection with Proteus. J Infect Dis. 1975 Feb;131(2):177–181. doi: 10.1093/infdis/131.2.177. [DOI] [PubMed] [Google Scholar]
  165. Mörsdorf G., Kaltwasser H. Cloning of the genes encoding urease from Proteus vulgaris and sequencing of the structural genes. FEMS Microbiol Lett. 1990 Jan 1;54(1-3):67–73. doi: 10.1016/0378-1097(90)90260-w. [DOI] [PubMed] [Google Scholar]
  166. Müller H. E. Occurrence and pathogenic role of Morganella-Proteus-Providencia group bacteria in human feces. J Clin Microbiol. 1986 Feb;23(2):404–405. doi: 10.1128/jcm.23.2.404-405.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. Nawrot U., Mokracka-Latajka G., Grzybek-Hryncewicz J., Krzyzanowska B., Jankowski S. Bactericidal activity of normal human serum against Morganella, Proteus, and Providencia strains. Acta Microbiol Pol. 1995;44(1):55–61. [PubMed] [Google Scholar]
  168. Nicholson E. B., Concaugh E. A., Foxall P. A., Island M. D., Mobley H. L. Proteus mirabilis urease: transcriptional regulation by UreR. J Bacteriol. 1993 Jan;175(2):465–473. doi: 10.1128/jb.175.2.465-473.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. Nicholson E. B., Concaugh E. A., Mobley H. L. Proteus mirabilis urease: use of a ureA-lacZ fusion demonstrates that induction is highly specific for urea. Infect Immun. 1991 Oct;59(10):3360–3365. doi: 10.1128/iai.59.10.3360-3365.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Nickel J. C., Emtage J., Costerton J. W. Ultrastructural microbial ecology of infection-induced urinary stones. J Urol. 1985 Apr;133(4):622–627. doi: 10.1016/s0022-5347(17)49116-6. [DOI] [PubMed] [Google Scholar]
  171. Nikaido H., Vaara M. Molecular basis of bacterial outer membrane permeability. Microbiol Rev. 1985 Mar;49(1):1–32. doi: 10.1128/mr.49.1.1-32.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Nixdorff K., Fitzer H., Gmeiner J., Martin H. H. Reconstitution of model membranes from phospholipid and outer membrane proteins of Proteus mirabilis. Role of proteins in the formation of hydrophilic pores and protection of membranes against detergents. Eur J Biochem. 1977 Nov 15;81(1):63–69. doi: 10.1111/j.1432-1033.1977.tb11927.x. [DOI] [PubMed] [Google Scholar]
  173. O'Brien I. G., Cox G. B., Gibson F. Biologically active compounds containing 2,3-dihydroxybenzoic acid and serine formed by Escherichia coli. Biochim Biophys Acta. 1970 Mar 24;201(3):453–460. doi: 10.1016/0304-4165(70)90165-0. [DOI] [PubMed] [Google Scholar]
  174. Old D. C., Adegbola R. A. Antigenic relationships among type-3 fimbriae of Enterobacteriaceae revealed by immunoelectronmicroscopy. J Med Microbiol. 1985 Aug;20(1):113–121. doi: 10.1099/00222615-20-1-113. [DOI] [PubMed] [Google Scholar]
  175. Old D. C., Adegbola R. A. Haemagglutinins and fimbriae of Morganella, Proteus and Providencia. J Med Microbiol. 1982 Nov;15(4):551–564. doi: 10.1099/00222615-15-4-551. [DOI] [PubMed] [Google Scholar]
  176. PHILLIPS J. E. In vitro studies on Proteus organisms of animal origin. J Hyg (Lond) 1955 Mar;53(1):26–31. doi: 10.1017/s0022172400000486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  177. Payne S. M. Iron and virulence in the family Enterobacteriaceae. Crit Rev Microbiol. 1988;16(2):81–111. doi: 10.3109/10408418809104468. [DOI] [PubMed] [Google Scholar]
  178. Peerbooms P. G., Marian A., Verweij J. J., MacLaren D. M. Urinary virulence of Proteus mirabilis in two experimental mouse models. Infect Immun. 1982 Jun;36(3):1246–1248. doi: 10.1128/iai.36.3.1246-1248.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  179. Peerbooms P. G., Verweij A. M., MacLaren D. M. Investigation of the haemolytic activity of Proteus mirabilis strains. Antonie Van Leeuwenhoek. 1983 Apr;49(1):1–11. doi: 10.1007/BF00457874. [DOI] [PubMed] [Google Scholar]
  180. Peerbooms P. G., Verweij A. M., MacLaren D. M. Uropathogenic properties of Proteus mirabilis and Proteus vulgaris. J Med Microbiol. 1985 Feb;19(1):55–60. doi: 10.1099/00222615-19-1-55. [DOI] [PubMed] [Google Scholar]
  181. Peerbooms P. G., Verweij A. M., MacLaren D. M. Vero cell invasiveness of Proteus mirabilis. Infect Immun. 1984 Mar;43(3):1068–1071. doi: 10.1128/iai.43.3.1068-1071.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Penner J. L., Hinton N. A., Whiteley G. R., Hennessy J. N. Variation in urease activity of endemic hospital strains of Proteus rettgeri and Providencia stuartii. J Infect Dis. 1976 Oct;134(4):370–376. doi: 10.1093/infdis/134.4.370. [DOI] [PubMed] [Google Scholar]
  183. Perry M. B., MacLean L. L. The structure of the polysaccharide produced by Proteus vulgaris (ATCC 49990). Carbohydr Res. 1994 Feb 3;253:257–263. doi: 10.1016/0008-6215(94)80070-7. [DOI] [PubMed] [Google Scholar]
  184. Piccolomini R., Cellini L., Allocati N., Di Girolamo A., Ravagnan G. Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections. Antimicrob Agents Chemother. 1987 Oct;31(10):1644–1647. doi: 10.1128/aac.31.10.1644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Plaut A. G. The IgA1 proteases of pathogenic bacteria. Annu Rev Microbiol. 1983;37:603–622. doi: 10.1146/annurev.mi.37.100183.003131. [DOI] [PubMed] [Google Scholar]
  186. Pollack J. R., Neilands J. B. Enterobactin, an iron transport compound from Salmonella typhimurium. Biochem Biophys Res Commun. 1970 Mar 12;38(5):989–992. doi: 10.1016/0006-291x(70)90819-3. [DOI] [PubMed] [Google Scholar]
  187. Radziejewska-Lebrecht J., Feige U., Jensen M., Kotełko K., Friebolin H., Mayer H. Structural studies on the glucose-heptose region of the Proteus mirabilis R core. Eur J Biochem. 1980;107(1):31–38. doi: 10.1111/j.1432-1033.1980.tb04620.x. [DOI] [PubMed] [Google Scholar]
  188. Radziejewska-Lebrecht J., Mayer H. The core region of Proteus mirabilis R110/1959 lipopolysaccharide. Eur J Biochem. 1989 Aug 15;183(3):573–581. doi: 10.1111/j.1432-1033.1989.tb21086.x. [DOI] [PubMed] [Google Scholar]
  189. Radziejewska-Lebrecht J., Shashkov A. S., Vinogradov E. V., Grosskurth H., Bartodziejska B., Rozalski A., Kaca W., Kononov L. O., Chernyak A. Y., Mayer H. Structure and epitope characterisation of the O-specific polysaccharide of Proteus mirabilis O28 containing amides of D-galacturonic acid with L-serine and L-lysine. Eur J Biochem. 1995 Jun 1;230(2):705–712. doi: 10.1111/j.1432-1033.1995.tb20612.x. [DOI] [PubMed] [Google Scholar]
  190. Radziejewska-Lebrecht J., Zych K., Lipińska M., Sidorczyk Z. Dalsze typy polisacharydu rdzeniowego (core) rodzaju Proteus. Med Dosw Mikrobiol. 1993;45(1):65–68. [PubMed] [Google Scholar]
  191. Rando D., Steglitz U., Mörsdorf G., Kaltwasser H. Nickel availability and urease expression in Proteus mirabilis. Arch Microbiol. 1990;154(5):428–432. doi: 10.1007/BF00245222. [DOI] [PubMed] [Google Scholar]
  192. Raoult D., Dasch G. A. Immunoblot cross-reactions among Rickettsia, Proteus spp. and Legionella spp. in patients with Mediterranean spotted fever. FEMS Immunol Med Microbiol. 1995 Mar;11(1):13–18. doi: 10.1111/j.1574-695X.1995.tb00073.x. [DOI] [PubMed] [Google Scholar]
  193. Reid G., Sobel J. D. Bacterial adherence in the pathogenesis of urinary tract infection: a review. Rev Infect Dis. 1987 May-Jun;9(3):470–487. doi: 10.1093/clinids/9.3.470. [DOI] [PubMed] [Google Scholar]
  194. Rietschel E. T., Kirikae T., Schade F. U., Mamat U., Schmidt G., Loppnow H., Ulmer A. J., Zähringer U., Seydel U., Di Padova F. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 1994 Feb;8(2):217–225. doi: 10.1096/fasebj.8.2.8119492. [DOI] [PubMed] [Google Scholar]
  195. Roberts J. A., Fussell E. N., Kaack M. B. Bacterial adherence to urethral catheters. J Urol. 1990 Aug;144(2 Pt 1):264–269. doi: 10.1016/s0022-5347(17)39428-4. [DOI] [PubMed] [Google Scholar]
  196. Rosenstein I. J., Hamilton-Miller J. M., Brumfitt W. Role of urease in the formation of infection stones: comparison of ureases from different sources. Infect Immun. 1981 Apr;32(1):32–37. doi: 10.1128/iai.32.1.32-37.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  197. Rosenstein I. J. Urinary calculi: microbiological and crystallographic studies. Crit Rev Clin Lab Sci. 1986;23(3):245–277. doi: 10.3109/10408368609165802. [DOI] [PubMed] [Google Scholar]
  198. Rozalski A., Brade L., Kosma P., Appelmelk B. J., Krogmann C., Brade H. Epitope specificities of murine monoclonal and rabbit polyclonal antibodies against enterobacterial lipopolysaccharides of the Re chemotype. Infect Immun. 1989 Sep;57(9):2645–2652. doi: 10.1128/iai.57.9.2645-2652.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. Rozalski A., Kotełko K. Hemolytic activity and invasiveness in strains of Proteus penneri. J Clin Microbiol. 1987 Jun;25(6):1094–1096. doi: 10.1128/jcm.25.6.1094-1096.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  200. Rózalski A., Bartodziejska B., Wykrota M., Serwecińska L., Lukomski S., Kotełko K. Charakterystyka aktywności hemolitycznej Proteus penneri. Med Dosw Mikrobiol. 1993;45(1):79–83. [PubMed] [Google Scholar]
  201. Rózalski A., Długońska H., Kotełko K. Cell invasiveness of Proteus mirabilis and Proteus vulgaris strains. Arch Immunol Ther Exp (Warsz) 1986;34(5-6):505–512. [PubMed] [Google Scholar]
  202. Rózalski A., Wykrota M. Some biological features of proteus bacilli. 3. Comparison of haemolytic activity of Proteus and Serratia strains. Acta Microbiol Pol. 1986;35(1-2):57–59. [PubMed] [Google Scholar]
  203. SCOTT T. G. The bacteriology of urinary infections in paraplegia. J Clin Pathol. 1960 Jan;13:54–57. doi: 10.1136/jcp.13.1.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  204. Sareneva T., Holthöfer H., Korhonen T. K. Tissue-binding affinity of Proteus mirabilis fimbriae in the human urinary tract. Infect Immun. 1990 Oct;58(10):3330–3336. doi: 10.1128/iai.58.10.3330-3336.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  205. Savoia D., Martinetto P., Achino A., Pugliese A. Adhesion of Proteus species to various cell types. Eur J Clin Microbiol. 1983 Dec;2(6):571–576. doi: 10.1007/BF02016568. [DOI] [PubMed] [Google Scholar]
  206. Schindler M., Osborn M. J. Interaction of divalent cations and polymyxin B with lipopolysaccharide. Biochemistry. 1979 Oct 2;18(20):4425–4430. doi: 10.1021/bi00587a024. [DOI] [PubMed] [Google Scholar]
  207. Senior B. W., Albrechtsen M., Kerr M. A. A survey of IgA protease production among clinical isolates of Proteeae. J Med Microbiol. 1988 Jan;25(1):27–31. doi: 10.1099/00222615-25-1-27. [DOI] [PubMed] [Google Scholar]
  208. Senior B. W., Albrechtsen M., Kerr M. A. Proteus mirabilis strains of diverse type have IgA protease activity. J Med Microbiol. 1987 Sep;24(2):175–180. doi: 10.1099/00222615-24-2-175. [DOI] [PubMed] [Google Scholar]
  209. Senior B. W., Bradford N. C., Simpson D. S. The ureases of Proteus strains in relation to virulence for the urinary tract. J Med Microbiol. 1980 Nov;13(4):507–512. doi: 10.1099/00222615-13-4-507. [DOI] [PubMed] [Google Scholar]
  210. Senior B. W., Leslie D. L. Rare occurrence of Proteus vulgaris in faeces: a reason for its rare association with urinary tract infections. J Med Microbiol. 1986 Mar;21(2):139–144. doi: 10.1099/00222615-21-2-139. [DOI] [PubMed] [Google Scholar]
  211. Senior B. W., Loomes L. M., Kerr M. A. The production and activity in vivo of Proteus mirabilis IgA protease in infections of the urinary tract. J Med Microbiol. 1991 Oct;35(4):203–207. doi: 10.1099/00222615-35-4-203. [DOI] [PubMed] [Google Scholar]
  212. Senior B. W., McBride P. D., Morley K. D., Kerr M. A. The detection of raised levels of IgM to Proteus mirabilis in sera from patients with rheumatoid arthritis. J Med Microbiol. 1995 Sep;43(3):176–184. doi: 10.1099/00222615-43-3-176. [DOI] [PubMed] [Google Scholar]
  213. Senior B. W. The production of HlyA toxin by Proteus penneri strains. J Med Microbiol. 1993 Oct;39(4):282–289. doi: 10.1099/00222615-39-4-282. [DOI] [PubMed] [Google Scholar]
  214. Setia U., Serventi I., Lorenz P. Bacteremia in a long-term care facility. Spectrum and mortality. Arch Intern Med. 1984 Aug;144(8):1633–1635. [PubMed] [Google Scholar]
  215. Sharon N., Eshdat Y., Silverblatt F. J., Ofek I. Bacterial adherence to cell surface sugars. Ciba Found Symp. 1981;80:119–141. doi: 10.1002/9780470720639.ch9. [DOI] [PubMed] [Google Scholar]
  216. Shimizu T., Akiyama S., Masuzawa T., Yanagihara Y., Ikeda K., Takahashi T., Kondo H., Achiwa K. Biological activities of chemically synthesized Proteus-type lipid A. Microbiol Immunol. 1987;31(4):381–386. doi: 10.1111/j.1348-0421.1987.tb03099.x. [DOI] [PubMed] [Google Scholar]
  217. Sidorczyk Z., Kaca W., Brade H., Rietschel E. T., Sinnwell V., Zähringer U. Isolation and structural characterization of an 8-O-(4-amino-4-deoxy-beta-L-arabinopyranosyl)-3-deoxy-D-manno- octulosonic acid disaccharide in the lipopolysaccharide of a Proteus mirabilis deep rough mutant. Eur J Biochem. 1987 Oct 15;168(2):269–273. doi: 10.1111/j.1432-1033.1987.tb13416.x. [DOI] [PubMed] [Google Scholar]
  218. Sidorczyk Z., Kaca W., Kotelko K. Studies on lipopolysaccharides of Proteus vulgaris serogroups. Chemotypes of genus Proteus lipopolysaccharides. Bull Acad Pol Sci Biol. 1975;23(9):603–609. [PubMed] [Google Scholar]
  219. Sidorczyk Z., Rózalski A., Deka M., Kotełko K. Immunochemical studies on free lipid A from Proteus mirabilis 1959. Arch Immunol Ther Exp (Warsz) 1978;26(1-6):239–243. [PubMed] [Google Scholar]
  220. Sidorczyk Z., Swierzko A., Knirel Y. A., Vinogradov E. V., Chernyak A. Y., Kononov L. O., Cedzynski M., Rozalski A., Kaca W., Shashkov A. S. Structure and epitope specificity of the O-specific polysaccharide of Proteus penneri strain 12 (ATCC 33519) containing the amide of D-galacturonic acid with L-threonine. Eur J Biochem. 1995 Jun 1;230(2):713–721. [PubMed] [Google Scholar]
  221. Sidorczyk Z., Swierzko A., Vinogradov E. V., Knirel Y. A., Shashkov A. S. Structural and immunochemical studies on O-specific polysaccharide of Proteus penneri strain 14. Arch Immunol Ther Exp (Warsz) 1994;42(3):209–215. [PubMed] [Google Scholar]
  222. Sidorczyk Z., Swierzko A., Zych K., Shashkov A. S., Vinogradov E. V., Knirel Y. A. Badania immunochemiczne polisacharydu Q-swoistego lipopolisacharydu Proteus penneri 42. Med Dosw Mikrobiol. 1993;45(1):89–92. [PubMed] [Google Scholar]
  223. Sidorczyk Z., Zych K. Lipopolysaccharides of flagellated and non-flagellated Proteus vulgaris strains. Arch Immunol Ther Exp (Warsz) 1986;34(4):461–469. [PubMed] [Google Scholar]
  224. Sidorczyk Z., Zähringer U., Rietschel E. T. Chemical structure of the lipid A component of the lipopolysaccharide from a Proteus mirabilis Re-mutant. Eur J Biochem. 1983 Dec 1;137(1-2):15–22. doi: 10.1111/j.1432-1033.1983.tb07789.x. [DOI] [PubMed] [Google Scholar]
  225. Sidroczyk Z., Swierzko A., Lipińska M., Vinogradov E. V., Shashkov A. S., Knirel Y. A. Badania immunochemiczne polisacharydu O-swoistego lipopolisacharydu Proteus penneri 14. Med Dosw Mikrobiol. 1993;45(1):85–87. [PubMed] [Google Scholar]
  226. Silverblatt F. J. Host-parasite interaction in the rat renal pelvis: a possible role for pili in the pathogenesis of pyelonephritis. J Exp Med. 1974 Dec 1;140(6):1696–1711. doi: 10.1084/jem.140.6.1696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  227. Silverblatt F. J., Ofek I. Influence of pili on the virulence of Proteus mirabilis in experimental hematogenous pyelonephritis. J Infect Dis. 1978 Nov;138(5):664–667. doi: 10.1093/infdis/138.5.664. [DOI] [PubMed] [Google Scholar]
  228. Smith H. Pathogenicity and the microbe in vivo. The 1989 Fred Griffith Review Lecture. J Gen Microbiol. 1990 Mar;136(3):377–393. doi: 10.1099/00221287-136-3-377. [DOI] [PubMed] [Google Scholar]
  229. Sogaard H., Zimmermann-Nielsen C., Siboni K. Antibiotic-resistant gram-negative bacilli in a urological ward for male patients during a nine-year period: relationship to antibiotic consumption. J Infect Dis. 1974 Dec;130(6):646–650. doi: 10.1093/infdis/130.6.646. [DOI] [PubMed] [Google Scholar]
  230. Sriwanthana B., Island M. D., Maneval D., Mobley H. L. Single-step purification of Proteus mirabilis urease accessory protein UreE, a protein with a naturally occurring histidine tail, by nickel chelate affinity chromatography. J Bacteriol. 1994 Nov;176(22):6836–6841. doi: 10.1128/jb.176.22.6836-6841.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  231. Sriwanthana B., Island M. D., Mobley H. L. Sequence of the Proteus mirabilis urease accessory gene ureG. Gene. 1993 Jul 15;129(1):103–106. doi: 10.1016/0378-1119(93)90703-6. [DOI] [PubMed] [Google Scholar]
  232. Stahl S. J., Stewart K. R., Williams F. D. Extracellular slime associated with Proteus mirabilis during swarming. J Bacteriol. 1983 May;154(2):930–937. doi: 10.1128/jb.154.2.930-937.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  233. Stintzing G., Tufvesson B., Habte D., Back E., Johnsson T., Wadstrom T. Aetiology of acute diarrhoeal disease in infancy and childhood, during the peak season Addis Ababa 1977: a preliminary report. Ethiop Med J. 1977 Oct;15(4):141–146. [PubMed] [Google Scholar]
  234. Sugawara E., Nikaido H. Pore-forming activity of OmpA protein of Escherichia coli. J Biol Chem. 1992 Feb 5;267(4):2507–2511. [PubMed] [Google Scholar]
  235. Svanborg Edén C., Hausson S., Jodal U., Lidin-Janson G., Lincoln K., Linder H., Lomberg H., de Man P., Mårild S., Martinell J. Host-parasite interaction in the urinary tract. J Infect Dis. 1988 Mar;157(3):421–426. doi: 10.1093/infdis/157.3.421. [DOI] [PubMed] [Google Scholar]
  236. Swihart K. G., Welch R. A. Cytotoxic activity of the Proteus hemolysin HpmA. Infect Immun. 1990 Jun;58(6):1861–1869. doi: 10.1128/iai.58.6.1861-1869.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  237. Swihart K. G., Welch R. A. The HpmA hemolysin is more common than HlyA among Proteus isolates. Infect Immun. 1990 Jun;58(6):1853–1860. doi: 10.1128/iai.58.6.1853-1860.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  238. Süsskind M., Müller-Loennies S., Nimmich W., Brade H., Holst O. Structural investigation on the carbohydrate backbone of the lipopolysaccharide from Klebsiella pneumoniae rough mutant R20/O1-. Carbohydr Res. 1995 Apr 3;269(1):C1–C7. doi: 10.1016/0008-6215(95)00002-b. [DOI] [PubMed] [Google Scholar]
  239. Tolson D. L., Barrigar D. L., McLean R. J., Altman E. Expression of a nonagglutinating fimbria by Proteus mirabilis. Infect Immun. 1995 Mar;63(3):1127–1129. doi: 10.1128/iai.63.3.1127-1129.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  240. Uhrín D., Brisson J. R., MacLean L. L., Richards J. C., Perry M. B. Application of 1D and 2D NMR techniques to the structure elucidation of the O-polysaccharide from Proteus mirabilis O:57. J Biomol NMR. 1994 Sep;4(5):615–630. doi: 10.1007/BF00404273. [DOI] [PubMed] [Google Scholar]
  241. Uphoff T. S., Welch R. A. Nucleotide sequencing of the Proteus mirabilis calcium-independent hemolysin genes (hpmA and hpmB) reveals sequence similarity with the Serratia marcescens hemolysin genes (shlA and shlB). J Bacteriol. 1990 Mar;172(3):1206–1216. doi: 10.1128/jb.172.3.1206-1216.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  242. Vaara M. Agents that increase the permeability of the outer membrane. Microbiol Rev. 1992 Sep;56(3):395–411. doi: 10.1128/mr.56.3.395-411.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  243. Vaara M., Vaara T., Jensen M., Helander I., Nurminen M., Rietschel E. T., Mäkelä P. H. Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium. FEBS Lett. 1981 Jun 29;129(1):145–149. doi: 10.1016/0014-5793(81)80777-6. [DOI] [PubMed] [Google Scholar]
  244. Vaara M., Viljanen P. Binding of polymyxin B nonapeptide to gram-negative bacteria. Antimicrob Agents Chemother. 1985 Apr;27(4):548–554. doi: 10.1128/aac.27.4.548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  245. Vinogradov E. V., Kaca W., Knirel Y. A., Rózalski A., Kochetkov N. K. Structural studies on the fucosamine-containing O-specific polysaccharide of Proteus vulgaris O19. Eur J Biochem. 1989 Mar 1;180(1):95–99. doi: 10.1111/j.1432-1033.1989.tb14619.x. [DOI] [PubMed] [Google Scholar]
  246. Vinogradov E. V., Kaca W., Rózalski A., Shashkov A. S., Cedzynski M., Knirel Y. A., Kochetkov N. K. Structural and immunochemical studies of O-specific polysaccharide of Proteus vulgaris 5/43 belonging to OX19 group (O-variants). Eur J Biochem. 1991 Aug 15;200(1):195–201. doi: 10.1111/j.1432-1033.1991.tb21067.x. [DOI] [PubMed] [Google Scholar]
  247. Vinogradov E. V., Kaca W., Shashkov A. S., Krajewska-Pietrasik D., Rozalski A., Knirel Y. A., Kochetkov N. K. The structure of Proteus mirabilis O3 O-specific polysaccharide containing N-(2-hydroxyethyl)-D-alanine. Eur J Biochem. 1990 Mar 30;188(3):645–651. doi: 10.1111/j.1432-1033.1990.tb15446.x. [DOI] [PubMed] [Google Scholar]
  248. Vinogradov E. V., Krajewska-Pietrasik D., Kaca W., Shashkov A. S., Knirel Y. A., Kochetkov N. K. Structure of Proteus mirabilis O27 O-specific polysaccharide containing amino acids and phosphoethanolamine. Eur J Biochem. 1989 Nov 20;185(3):645–650. doi: 10.1111/j.1432-1033.1989.tb15161.x. [DOI] [PubMed] [Google Scholar]
  249. Vinogradov E. V., Shashkov A. S., Knirel Y. A., Kochetkov N. K., Sidorczyk Z., Swierzko A. The structure of Proteus penneri strain 14-O-specific polysaccharide containing D- and L-alanine. Carbohydr Res. 1991 Oct 14;219:c1–c3. doi: 10.1016/0008-6215(91)89059-o. [DOI] [PubMed] [Google Scholar]
  250. Vinogradov E. V., Sidorczyk Z., Swierzko A., Rozalski A., Daeva E. D., Shashkov A. S., Knirel Y. A., Kochetkov N. K. The structure of the O-specific polysaccharide chain of Proteus penneri strain 16 lipopolysaccharide. Eur J Biochem. 1991 Apr 10;197(1):93–103. doi: 10.1111/j.1432-1033.1991.tb15886.x. [DOI] [PubMed] [Google Scholar]
  251. Wadström T., Aust-Kettis A., Habte D., Holmgren J., Meeuwisse G., Möllby R., Söderlind O. Enterotoxin-producing bacteria and parasites in stools of Ethiopian children with diarrhoeal disease. Arch Dis Child. 1976 Nov;51(11):865–870. doi: 10.1136/adc.51.11.865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  252. Walz S. E., Wray S. K., Hull S. I., Hull R. A. Multiple proteins encoded within the urease gene complex of Proteus mirabilis. J Bacteriol. 1988 Mar;170(3):1027–1033. doi: 10.1128/jb.170.3.1027-1033.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  253. Warren J. W., Damron D., Tenney J. H., Hoopes J. M., Deforge B., Muncie H. L., Jr Fever, bacteremia, and death as complications of bacteriuria in women with long-term urethral catheters. J Infect Dis. 1987 Jun;155(6):1151–1158. doi: 10.1093/infdis/155.6.1151. [DOI] [PubMed] [Google Scholar]
  254. Warren J. W., Tenney J. H., Hoopes J. M., Muncie H. L., Anthony W. C. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis. 1982 Dec;146(6):719–723. doi: 10.1093/infdis/146.6.719. [DOI] [PubMed] [Google Scholar]
  255. Wassif C., Cheek D., Belas R. Molecular analysis of a metalloprotease from Proteus mirabilis. J Bacteriol. 1995 Oct;177(20):5790–5798. doi: 10.1128/jb.177.20.5790-5798.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  256. Weber G., Heck D., Bartlett R. R., Nixdorff K. Modulation of effects of lipopolysaccharide on macrophages by a major outer membrane protein of Proteus mirabilis as measured in a chemiluminescence assay. Infect Immun. 1992 Mar;60(3):1069–1075. doi: 10.1128/iai.60.3.1069-1075.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  257. Weber G., Link F., Ferber E., Munder P. G., Zeitter D., Bartlett R. R., Nixdorff K. Differential modulation of the effects of lipopolysaccharide on macrophages by a major outer membrane protein of Proteus mirabilis. J Immunol. 1993 Jul 1;151(1):415–424. [PubMed] [Google Scholar]
  258. Welch R. A., Forestier C., Lobo A., Pellett S., Thomas W., Jr, Rowe G. The synthesis and function of the Escherichia coli hemolysin and related RTX exotoxins. FEMS Microbiol Immunol. 1992 Sep;5(1-3):29–36. doi: 10.1111/j.1574-6968.1992.tb05883.x. [DOI] [PubMed] [Google Scholar]
  259. Welch R. A. Identification of two different hemolysin determinants in uropathogenic Proteus isolates. Infect Immun. 1987 Sep;55(9):2183–2190. doi: 10.1128/iai.55.9.2183-2190.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  260. Welch R. A. Pore-forming cytolysins of gram-negative bacteria. Mol Microbiol. 1991 Mar;5(3):521–528. doi: 10.1111/j.1365-2958.1991.tb00723.x. [DOI] [PubMed] [Google Scholar]
  261. Wenner J. J., Rettger L. F. A Systematic Study of the Proteus Group of Bacteria. J Bacteriol. 1919 Jul;4(4):331–353. doi: 10.1128/jb.4.4.331-353.1919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  262. Williams F. D., Schwarzhoff R. H. Nature of the swarming phenomenon in Proteus. Annu Rev Microbiol. 1978;32:101–122. doi: 10.1146/annurev.mi.32.100178.000533. [DOI] [PubMed] [Google Scholar]
  263. Wray S. K., Hull S. I., Cook R. G., Barrish J., Hull R. A. Identification and characterization of a uroepithelial cell adhesin from a uropathogenic isolate of Proteus mirabilis. Infect Immun. 1986 Oct;54(1):43–49. doi: 10.1128/iai.54.1.43-49.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  264. Yakubu D. E., Old D. C., Senior B. W. The haemagglutinins and fimbriae of Proteus penneri. J Med Microbiol. 1989 Dec;30(4):279–284. doi: 10.1099/00222615-30-4-279. [DOI] [PubMed] [Google Scholar]
  265. Zych K., Sidorczyk Z. Lipopolysaccharides of Proteus penneri species novum. Carbohydr Res. 1989 Jun 1;188:105–111. doi: 10.1016/0008-6215(89)84063-7. [DOI] [PubMed] [Google Scholar]

Articles from Microbiology and Molecular Biology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES